Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Fintel reports that on November 5, 2024, Piper Sandler initiated coverage of Camp4 Therapeutics (NasdaqGM:CAMP) with a Overweight recommendation. Analyst Price Forecast Suggests 173.74% Upside As of ...

In a report released today, Peter Keith from Piper Sandler maintained a Hold rating on Dollar Tree (DLTR – Research Report), with a price ...

Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on Lineage, Inc. (LINE – Research Report) today and set a price target ...

Such findings raised questions about the added benefit of masofaniten, leading ESSA to abandon the drug’s development. In light of these results, Piper Sandler removed any projected value for ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...

Operator: Good morning. And welcome to the Piper Sandler Companies’ Third Quarter 2024 Earnings Conference Call.

Piper Sandler Companies (NYSE:PIPR), a leading investment bank and institutional securities firm, has demonstrated resilience and strategic growth in a dynamic financial landscape. The company's ...

Good morning and welcome to the Piper Sandler Company's third quarter, 2024 earnings conference call. Today's call is being recorded and will include remarks by Piper Sandler management followed ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research ...